Gilead Sciences to Present at Upcoming Investor Engagements
Gilead Sciences (GILD) has announced its executives' participation in three major investor conferences: the Jefferies London Healthcare Conference on November 20 at 9:30 AM GMT, the Piper Sandler Annual Healthcare Conference on December 3 at 11:00 AM ET, and the Annual Evercore ISI HealthCONx Conference on December 4 at 11:40 AM ET.
Live webcasts will be available on the company's investor page, with replays accessible for at least 30 days post-presentation. Gilead Sciences is a biopharmaceutical company focused on developing innovative medicines for HIV, viral hepatitis, COVID-19, and cancer, operating in over 35 countries worldwide.
Gilead Sciences (GILD) ha annunciato la partecipazione dei suoi dirigenti a tre importanti conferenze per investitori: la Jefferies London Healthcare Conference il 20 novembre alle 9:30 GMT, la Piper Sandler Annual Healthcare Conference il 3 dicembre alle 11:00 ET e la Annual Evercore ISI HealthCONx Conference il 4 dicembre alle 11:40 ET.
Le dirette streaming saranno disponibili sulla pagina dedicata agli investitori dell'azienda, con replay accessibili per almeno 30 giorni dopo la presentazione. Gilead Sciences è un'azienda biofarmaceutica focalizzata sullo sviluppo di medicinali innovativi per l'HIV, l'epatite virale, il COVID-19 e il cancro, operando in oltre 35 paesi nel mondo.
Gilead Sciences (GILD) ha anunciado la participación de sus ejecutivos en tres importantes conferencias para inversores: la Jefferies London Healthcare Conference el 20 de noviembre a las 9:30 AM GMT, la Piper Sandler Annual Healthcare Conference el 3 de diciembre a las 11:00 AM ET y la Annual Evercore ISI HealthCONx Conference el 4 de diciembre a las 11:40 AM ET.
Las transmisiones en vivo estarán disponibles en la página de inversores de la empresa, con repeticiones accesibles durante al menos 30 días después de la presentación. Gilead Sciences es una empresa biofarmacéutica centrada en el desarrollo de medicamentos innovadores para el VIH, la hepatitis viral, el COVID-19 y el cáncer, operando en más de 35 países en todo el mundo.
Gilead Sciences (GILD)는 임원들이 세 가지 주요 투자자 회의에 참석할 것이라고 발표했습니다: Jefferies London Healthcare Conference는 11월 20일 GMT 9:30에, Piper Sandler Annual Healthcare Conference는 12월 3일 ET 11:00에, Annual Evercore ISI HealthCONx Conference는 12월 4일 ET 11:40에 열립니다.
생중계는 회사의 투자자 페이지에서 제공되며, 발표 후 최소 30일 동안 다시 시청할 수 있습니다. Gilead Sciences는 HIV, 바이러스 간염, COVID-19 및 암을 위한 혁신적인 의약품 개발에 주력하는 생명공학 회사로, 전 세계 35개국 이상에서 운영되고 있습니다.
Gilead Sciences (GILD) a annoncé la participation de ses dirigeants à trois grandes conférences d'investisseurs : la Jefferies London Healthcare Conference le 20 novembre à 9h30 GMT, la Piper Sandler Annual Healthcare Conference le 3 décembre à 11h00 ET, et la Annual Evercore ISI HealthCONx Conference le 4 décembre à 11h40 ET.
Les webinaires en direct seront disponibles sur la page des investisseurs de l'entreprise, avec des rediffusions accessibles pendant au moins 30 jours après la présentation. Gilead Sciences est une entreprise biopharmaceutique axée sur le développement de médicaments innovants pour le VIH, l'hépatite virale, le COVID-19 et le cancer, opérant dans plus de 35 pays à travers le monde.
Gilead Sciences (GILD) hat die Teilnahme seiner Führungskräfte an drei wichtigen Investorenkonferenzen angekündigt: die Jefferies London Healthcare Conference am 20. November um 9:30 Uhr GMT, die Piper Sandler Annual Healthcare Conference am 3. Dezember um 11:00 Uhr ET und die Annual Evercore ISI HealthCONx Conference am 4. Dezember um 11:40 Uhr ET.
Live-Webcasts werden auf der Investoren-Seite des Unternehmens verfügbar sein, mit Wiederholungen, die mindestens 30 Tage nach der Präsentation zugänglich sind. Gilead Sciences ist ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung innovativer Medikamente für HIV, virale Hepatitis, COVID-19 und Krebs konzentriert und in über 35 Ländern weltweit tätig ist.
- None.
- None.
- Jefferies London Healthcare Conference on Wednesday, November 20 at 9:30 AM Greenwich Mean Time
- Piper Sandler Annual Healthcare Conference on Tuesday, December 3 at 11:00 AM Eastern Time
- Annual Evercore ISI HealthCONx Conference on Wednesday, December 4 at 11:40 AM Eastern Time
The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241108042891/en/
Jacquie Ross, CFA – Investors
investor_relations@gilead.com
Source: Gilead Sciences, Inc.
FAQ
When is Gilead Sciences (GILD) presenting at the Jefferies London Healthcare Conference?
How long will the webcasts of Gilead's (GILD) investor conferences be available?
Which investor conferences is Gilead Sciences (GILD) attending in December?
Where can investors access Gilead Sciences' (GILD) conference webcasts?
